LINEA System is a Clinical Services/Technology company specializing in applying data intelligence and cutting edge technology to revolutionize clinical trials. Our goal is to provide clients with high quality, cost-effective and competitive solutions that help advance clinical trials. To achieve this goal, we leverage our collective experience in drug development, clinical, analytics, data intelligence and advanced technology for clinical trial solutions.
Our team consists of individuals who have managed the same challenges healthcare teams are facing today. We have managed priority projects at many organizational levels and in various therapeutic areas.
“It brings to the table data driven analytics, business process mapping and modeling, and integrated solutions intended for our clients to help advance patient care and achieve the greatest value for their investments”
We intimately understand the interdependencies of all the moving parts in the clinical trial process. Our solutions provide our clients a competitive advantage in advancing clinical trials and perfecting the site identification and on boarding process to quickly get access to patients.
When you work with LINEA, your team will enjoy higher productivity with renewed clarity and an objective approach to startup of clinical trials eliminating cost overruns and unnecessary delays.
Our model is repeatable.
LINEA System is a clinical service and technology firm working with pharma to speed clinical trial site identification and start up. LINEA was founded in 2007 to provide a service that is urgently needed in the pharma industry: recruiting the right sites to meet patient recruitment targets in the clinical trials. I have spent my working career in life sciences – much of it in drug development running the clinical trials. The forming of LINEA was based on drawing from my own clinical experience and first-hand challenges with patient recruitment and trial startup.
Our first patient recruitment project was granted by a small biotech and it involved referring patients to sites supporting a pivotal trial. This experience was successful and we realized that although finding the patients was great, we still needed good sites to enroll the patients. We focused our services on identifying and recommending highly qualified sites based on self-reporting data, and yet there was still a gap in the site’s ability to put patients on trial. We started conducting research on how to improve site identification by leveraging big data and technology. From the result of this extensive research and a major technology development project, emerged a system that objectively identifies the right sites and eases the activation process, AcceleTrial.
Many vendors in the market have nice outputs but their core data quality doesn’t change –still self-identified and subjective. These vendors have nice presentation layers and they make it easy to access and integrate – yet the problem is not fixed. Why? Self-identified data that is not objective leads to gaps in results. What if you could go further with data quality and gaining intelligence on the sites that would take the guess work out of the site’s ability to contribute patients? That is exactly what we did and perfected site identification and activation using AcceleTrial.
Why did we decide to take on a monumental problem in this industry and try to solve it?
The answer is simple. We believe the best opportunity to improve clinical trials is in site identification and trial startup. If the clinical trial startup is quicker and contains better sites, great things happen for sponsors and more importantly for the patients. We believe AcceleTrial can make an industry wide impact on the clinical trial process and accelerating the rate of bringing new medicines to market.
Kathleen Colatrella is a leading expert in clinical research. She has over fifteen years of experience in the pharmaceutical industry in large and biotech companies. Previously, she held senior positions in Research and Development at Mannkind Corporation, Genta Inc., and Roche. She led the clinical teams responsible for the filing of four NDA approvals for lead products including managing FDA Advisory Meetings.
She has dedicated her career to working closely with the pharmaceutical companies to accelerate clinical trials by perfecting site identification and impacting the trial launch process. Utilizing her healthcare background and clinical experience she has helped others in the industry achieve success linking data analytics and technology. Most recently, Kathleen and her team developed a breakthrough solution, AcceleTrial with a mission to deliver a transformational way for the industry to identify and activate sites for clinical trials.
VP of Technology
Marco Asbreuk is referred to as an Internet Wizard in the Web-application industry. Marco has 15 years’ experience as a Software/Frontend/Backend Engineer. In 2016, Marco joined LINEA System LLC as a consultant where he leads the development of AcceleTrial. Prior to LINEA, he operated his own business where he built high-tech b2b web applications for multiple industries.
Associate Director of Project Management
Hamita Patel is Associate Director of Project Management for LINEA System LLC with extensive experience in clinical research. Hamita is responsible for the technical management of LINEA’s AcceleTrial application throughout the development lifecycle from start to finish. Hamita also oversees the development and coordination of planning across function projects. Her former roles include Project Manager and Clinical Project Coordinator where she was part of the data management.
Vice President of Operations
Leticia Bidó is Vice President of Operations for LINEA System LLC with extensive experience in personnel management and business development. Oversees delivery of the company’s services, client-facing project management lead; execute accounts payable functions, manage procurement services, assist in contract negotiations, perform personnel management and provide business development support. She supports with software development and general marketing. She engages directly with clinical research sites and perform pre-qualification due diligence activities for clinical trial suitability. She creates strategy for prospecting investigative sites for recommendation to clinical trial programs.